Emami Ltd Gets CARE AA+ Rating Reaffirmed for ₹168 Crore Bank Facilities
CARE Ratings has reaffirmed Emami Limited's CARE AA+ Stable/CARE A1+ rating for bank facilities worth ₹168.00 crore. The rating reflects Emami's strong market position in the FMCG sector, robust financial performance with 6% revenue growth, and healthy PBILDT margin of 26.69%. The company maintains a strong capital structure with minimal debt and solid liquidity. Despite slight moderation in performance due to weather conditions and GST-related disruptions, Emami's extensive distribution network and strategic investments in brand strengthening support its stable outlook.

*this image is generated using AI for illustrative purposes only.
Emami Limited has received a credit rating reaffirmation from CARE Ratings Limited, maintaining its strong financial standing in the fast-moving consumer goods sector. The rating agency announced that it has reaffirmed the company's CARE AA+ Stable/CARE A1+ rating for bank facilities worth ₹168.00 crore.
Rating Details and Rationale
The reaffirmed rating reflects Emami's established presence in the FMCG industry, supported by the extensive experience of its promoters and strong market positioning in ayurvedic and herbal personal care segments. CARE Ratings highlighted the company's robust financial performance, which showed growth in total operating income and continued healthy profitability margins.
| Rating Parameter | Details |
|---|---|
| Bank Facilities Amount | ₹168.00 crore |
| Long-term Rating | CARE AA+ Stable |
| Short-term Rating | CARE A1+ |
| Rating Action | Reaffirmed |
| Commercial Paper | Rating Withdrawn |
Financial Performance and Market Position
Emami demonstrated strong financial metrics with revenue growth of 6.00% year-on-year, driven by 7.00% growth in domestic business and 4.00% growth in international operations. The company maintained a healthy PBILDT margin of 26.69%, significantly above industry averages, supported by effective cost management across all functions.
The company's extensive distribution network spans 5.4 million retail outlets in India and operations in over 70 countries globally. Key brands including Boroplus, Navratna, Dermicool, Zandu, Mentho Plus Balm, Fair and Handsome, and Kesh King hold significant market shares in their respective segments.
Performance Moderation
CARE Ratings noted slight moderation in total operating income and operating margins, attributed to unfavorable weather conditions impacting summer product demand, particularly Dermicool and Navratna. Additionally, temporary trade disruptions following GST rate cuts deferred winter portfolio loading, mainly affecting Boroplus products.
| Performance Metric | Latest Reported | Previous Period |
|---|---|---|
| Total Operating Income | ₹3,797.38 crore | ₹3,574.37 crore |
| PBILDT | ₹1,013.49 crore | ₹945.81 crore |
| PAT | ₹802.74 crore | - |
Capital Structure and Liquidity Position
The rating agency emphasized Emami's robust capital structure with minimal debt levels. The overall gearing stood at 0.03x as of March 31, compared to 0.04x in the previous year. The company maintains strong liquidity with cash, bank, and liquid investment balances of ₹845.00 crore as of September 30.
Working capital limit utilization remained at negligible levels for the 12 months ended November, while the operating cycle improved to 47 days from 52 days in the previous period.
Strategic Investments and Brand Portfolio
Emami continues to invest in brand strengthening and inorganic growth, with advertisement and sales promotion expenses accounting for 18.28% of sales. The company has made strategic acquisitions including stakes in Helios Lifestyle (The Man Company), Brillare Science, Cannis Lupus Services (Fur Ball Story), and Axiom Group (Alo Frut brands).
Rating Outlook and Commercial Paper Withdrawal
CARE Ratings maintains a stable outlook, expecting Emami to sustain its healthy business risk profile supported by established brands and strong market positioning. The rating agency has withdrawn the commercial paper rating with immediate effect, as no commercial paper has been issued and no amount remains outstanding.
The company's performance is expected to improve in the second half, driven by recovery in demand post-GST rate cuts and repo rate reductions, which should enhance consumer purchasing power and benefit from Emami's strong brand positioning and wide distribution network.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.25% | +1.36% | +2.38% | -8.33% | -10.58% | +24.86% |
















































